Skip Navigation LinksHome > December 2013 - Volume 56 - Issue 4 > Osteoporosis: What’s New and on the Horizon
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e3182a9ece0
Osteoporosis: Diagnosis and Management

Osteoporosis: What’s New and on the Horizon

SILVA, BARBARA C. MD, PhD; COSTA, ALINE G. MD; CUSANO, NATALIE E. MD; BILEZIKIAN, JOHN P. MD

Collapse Box

Abstract

In this review, we consider new concepts in the assessment of fracture risk and pharmacologic therapy for osteoporosis. We discuss trabecular bone score, a new imaging technology that adds information that cannot be obtained by only measuring bone mineral density by dual-energy x-ray absorptiometry. We also discuss innovations in antiresorptive, osteoanabolic, and combination therapy; and newer therapeutic classes, including cathepsin K inhibitors and antisclerostin antibodies. We do not cover agents that have not yet been studied in human clinical trials or that are no longer under active investigation.

© 2013, Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.